|
|
|
Volumn 8, Issue 6, 2010, Pages 419-421
|
|
Immunotherapeutic approaches in prostate cancer: Provenge
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CANCER VACCINE;
DOCETAXEL;
GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR VACCINE;
PLACEBO;
PROSTATE VACCINE;
PROSTVAC;
PROVENGE;
UNCLASSIFIED DRUG;
ADVANCED CANCER;
ANDROGEN DEPRIVATION THERAPY;
ARTICLE;
BLOOD PRESSURE;
CANCER IMMUNOTHERAPY;
CHILL;
CLINICAL TRIAL;
DRUG APPROVAL;
DRUG CONTRAINDICATION;
DRUG MECHANISM;
DRUG TOLERABILITY;
FEVER;
FLU LIKE SYNDROME;
HEADACHE;
HUMAN;
PATIENT SELECTION;
PROSTATE CANCER;
SIDE EFFECT;
SURVIVAL TIME;
TREATMENT OUTCOME;
TREATMENT RESPONSE;
CLINICAL TRIALS AS TOPIC;
HUMANS;
IMMUNOTHERAPY;
MALE;
PROSTATIC NEOPLASMS;
TISSUE EXTRACTS;
|
|
EID: 77954484903
PISSN: 15430790
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (6)
|
|
References (2)
|
